173 related articles for article (PubMed ID: 10404926)
1. Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.
Moroney JT; Tseng CL; Paik MC; Mohr JP; Desmond DW
J Am Geriatr Soc; 1999 Jul; 47(7):824-9. PubMed ID: 10404926
[TBL] [Abstract][Full Text] [Related]
2. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke.
Mendelson G; Aronow WS
J Am Geriatr Soc; 1998 Nov; 46(11):1423-4. PubMed ID: 9809766
[TBL] [Abstract][Full Text] [Related]
3. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
[TBL] [Abstract][Full Text] [Related]
4. The specificity of prescription patterns in secondary stroke prevention.
Bellelli G; Trabucchi M
J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):512; author reply 512. PubMed ID: 14966188
[No Abstract] [Full Text] [Related]
5. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
[TBL] [Abstract][Full Text] [Related]
6. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
7. Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission.
Cohen N; Almoznino-Sarafian D; Alon I; Gorelik O; Koopfer M; Chachashvily S; Shteinshnaider M; Litvinjuk V; Modai D
Stroke; 2000 Jun; 31(6):1217-22. PubMed ID: 10835435
[TBL] [Abstract][Full Text] [Related]
8. Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure.
Kozdağ G; Yaymacı M; Ertaş G; Celikyurt U; Sahin T; Kılıç T; Ural D
Heart Vessels; 2012 Nov; 27(6):568-75. PubMed ID: 21909806
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and stroke prevention in the community.
O'Connell JE; Gray CS
Age Ageing; 1996 Jul; 25(4):307-9. PubMed ID: 8831876
[TBL] [Abstract][Full Text] [Related]
11. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP;
Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931
[TBL] [Abstract][Full Text] [Related]
12. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis.
Goldstein LB; Bonito AJ; Matchar DB; Duncan PW; Samsa GP
Stroke; 1996 Sep; 27(9):1473-8. PubMed ID: 8784115
[TBL] [Abstract][Full Text] [Related]
13. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.
Antani MR; Beyth RJ; Covinsky KE; Anderson PA; Miller DG; Cebul RD; Quinn LM; Landefeld CS
J Gen Intern Med; 1996 Dec; 11(12):713-20. PubMed ID: 9016417
[TBL] [Abstract][Full Text] [Related]
14. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
16. Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin.
Aronow WS; Ahn C; Kronzon I; Gutstein H
J Am Geriatr Soc; 1999 Mar; 47(3):366-8. PubMed ID: 10078902
[TBL] [Abstract][Full Text] [Related]
17. Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
Redman AR; Allen LC
Curr Atheroscler Rep; 2002 Jul; 4(4):319-25. PubMed ID: 12052284
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
[TBL] [Abstract][Full Text] [Related]
20. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
